Daily News

Recommended Therapies for Polycythemia Vera Underused

Recommended Therapies for Polycythemia Vera Underused

Phlebotomy and hydroxyurea tied to improved survival, lower risk for thrombosis in older patients.

Stringent Complete Response Criteria for Patients With Multiple Myeloma May Lack Predictive Value

Stringent Complete Response Criteria for Patients With Multiple Myeloma May Lack Predictive Value

By

Stringent CR criteria may not predict clinical outcomes for patients with multiple myeloma.

FDA Grants Approval to New Treatment for Acute Myeloid Leukemia

FDA Grants Approval to New Treatment for Acute Myeloid Leukemia

Randomized clinical trial showed significant improvement in overall survival with glasdegib.

A Retrospective Look at Drug Sensitivity Before and After Checkpoint Blockade in R/R NHL

A Retrospective Look at Drug Sensitivity Before and After Checkpoint Blockade in R/R NHL

By

Checkpoint-based therapies may sensitize patients to subsequent therapies.

Curative Option Identified for Squamous Cell Carcinoma of the Anal Canal With Distant Metastasis

Curative Option Identified for Squamous Cell Carcinoma of the Anal Canal With Distant Metastasis

By

A retrospective review identified a subset of patients with squamous cell carcinoma of the anal canal with distant metastases who respond to extended-field chemoradiation.

Perspectives on Use of Sensored Medication Devices From Patients With Multiple Myeloma

Perspectives on Use of Sensored Medication Devices From Patients With Multiple Myeloma

By

Researchers conducted a study to gauge the potential acceptance of sensored medication devices among patients with multiple myeloma.

Lung Cancer-Specific Distress Screening Tool Not Needed But Has Potential Benefit

Lung Cancer-Specific Distress Screening Tool Not Needed But Has Potential Benefit

By

Using focus groups, researchers evaluated patient-reported psychosocial consequences of lung cancer to determine if a lung cancer-specific distress screening instrument would benefit these patients.

Immunotherapy Side Effects May Be More Common Than Thought

Immunotherapy Side Effects May Be More Common Than Thought

Higher rates of adverse events observed for immune checkpoint inhibitors in real-world settings, compared to clinical trials.

Obesity as a Teen Ups Risk for Later Pancreatic Cancer

Obesity as a Teen Ups Risk for Later Pancreatic Cancer

In men, overweight and even higher normal weight is associated with an increased risk of future pancreatic cancer.

Risk for Colon Cancer, Osteogenic Sarcoma Higher With Presence of Diamond-Blackfan Anemia

Risk for Colon Cancer, Osteogenic Sarcoma Higher With Presence of Diamond-Blackfan Anemia

By

Researchers reviewed cancer incidence in patients with Diamond-Blackfan anemia.

G-CSF Support Increases Overall Survival, But Risk of Secondary Malignancies Also Higher

G-CSF Support Increases Overall Survival, But Risk of Secondary Malignancies Also Higher

By

A meta-analysis of 14 randomized, controlled trials was conducted to determine if combining G-CSF with intensified chemotherapy improved overall survival.

Report From Childhood Cancer Survivor Study Identifies Long-Term Risks for VTE

Report From Childhood Cancer Survivor Study Identifies Long-Term Risks for VTE

By

Assessment of long-term risks for VTE based on data from almost 30,000 childhood cancer survivors and siblings, with approximately 21 years of follow-up.

Outcomes Worse for Minimally Invasive Hysterectomy vs Open Surgery

Outcomes Worse for Minimally Invasive Hysterectomy vs Open Surgery

By

A comparison study of 2 approaches to radical hysterectomy found that disease-free and overall survival are worse with minimally invasive procedure than with abdominal open procedure, contradicting previous study findings.

Clinical Characteristics That Increase Risk of Chemotherapy-Induced Febrile Neutropenia Identified

Clinical Characteristics That Increase Risk of Chemotherapy-Induced Febrile Neutropenia Identified

By

Researchers analyzed data from more than 15,000 patients in Southern California with various cancers to identify clinical factors that contribute to the risk of developing chemotherapy-induced febrile neutropenia.

Dose-Escalation Mitigates Risk of Grade 3/4 Adverse Events With Ruxolitinib for Myelofibrosis

Dose-Escalation Mitigates Risk of Grade 3/4 Adverse Events With Ruxolitinib for Myelofibrosis

By

Results of an open-label phase 2 study demonstrated that a dose-escalation approach can prevent worsening anemia in patients with myelofibrosis undergoing treatment with ruxolitinib.

Patients and Caregivers Worry About Cost of Cancer Care

Patients and Caregivers Worry About Cost of Cancer Care

Survey also shows that Americans may be misinformed about alternative treatments for cancer.

Stem Cell Transplantation Superior to Chemotherapy for Relapsed/Refractory DLBCL, Follicular Lymphoma

Stem Cell Transplantation Superior to Chemotherapy for Relapsed/Refractory DLBCL, Follicular Lymphoma

By

A review of therapy options for relapsed/refractory DLBCL and FL compared SCT with chemotherapy/immunotherapy and experimental regimes. Patients fared better with SCT than other treatment modalities.

Head and Neck Cancer Survivors Have Increased Suicide Risk

Head and Neck Cancer Survivors Have Increased Suicide Risk

Survivors of head, neck cancers almost twice as likely to die from suicide as survivors of other cancers.

Study Reveals Relationship of Sleep Duration, Diabetes Risk in Cancer Survivors

Study Reveals Relationship of Sleep Duration, Diabetes Risk in Cancer Survivors

By

In a review of data from the National Health Interview Survey, researchers identified the relationship between short and long sleep durations and diabetes in cancer survivors.

Medication, Vaccination Uptake Improved by Involving Pharmacists in Elder Cancer Care

Medication, Vaccination Uptake Improved by Involving Pharmacists in Elder Cancer Care

By

Researchers explored the feasibility of integrating pharmacists into the oncology care team for older patients with cancer to determine the impact this intervention would have on medication management and vaccination uptake.

AAD Releases New Guidelines for the Treatment of Cutaneous Melanoma

AAD Releases New Guidelines for the Treatment of Cutaneous Melanoma

Guidelines recommend surgical excision as primary treatment modality, and emphasize individualized care.

Commission Seeks Standardized Adverse Event Assessments in Hematologic Malignancies

Commission Seeks Standardized Adverse Event Assessments in Hematologic Malignancies

By

A snapshot of an international Commission's report on the issues inherent with adverse event reports of hematologic malingnancies in clinical trials.

Molecular Features May Predict Response in Primary Pancreatic Cancer 

Molecular Features May Predict Response in Primary Pancreatic Cancer 

By

The goal of this study was to determine how molecular features change when PDAC progresses from a primary tumor to metastatic disease.

Leukemia Risk in Children, Maternal Use of Hormonal Contraception Linked in Population Study

Leukemia Risk in Children, Maternal Use of Hormonal Contraception Linked in Population Study

By

A prospective cohort study from Denmark investigated the link between maternal hormonal contraception use before — more than 3 months and within 3 months — and during pregnancy and risk of leukemia in their children.

Chemoimmunotherapy prolongs PFS in metastatic triple-negative breast cancer

Chemoimmunotherapy prolongs PFS in metastatic triple-negative breast cancer

By

A prospective analysis of patients with advanced cancer revealed the effect delirium has on palliative care and symptom management at baseline and after 7 days of treatment.

Barriers to Prostate Cancer Research in Black Men Identified

Barriers to Prostate Cancer Research in Black Men Identified

Mistrust, lack of knowledge, unfavorable attitudes are barriers to genomic testing, study participation

New Method Estimates Risk for Breast Cancer Recurrence

New Method Estimates Risk for Breast Cancer Recurrence

Higher recurrence risk linked to older age, more advanced stage, HR-negative tumors.

CheckMate 067 Gives Nivolumab Alone, With Ipilimumab the Nod in Advanced Melanoma

CheckMate 067 Gives Nivolumab Alone, With Ipilimumab the Nod in Advanced Melanoma

By

Survival and progression-free survival were better with nivolumab alone or with ipilimumab vs ipilimumab alone for stage III or IV melanoma with known BRAFV600 mutation, according to results of this randomized study.

PACC Guidelines Recommend IT Morphine, Ziconotide for Chronic Pain 

PACC Guidelines Recommend IT Morphine, Ziconotide for Chronic Pain 

By

The 2016 evidence-based PACC guidelines recommend the use of morphine and ziconotide as effective and safe first-line IT monotherapies for chronic pain.

ASCO, SITC Release Recommendations for Clinical Trial Reporting of Immunotherapy Adverse Events

ASCO, SITC Release Recommendations for Clinical Trial Reporting of Immunotherapy Adverse Events

By

As immunotherapies gain a stronger foothold as a treatment option for cancer, ASCO and SITC convened a panel to develop recommendations to ensure consistent and efficient clinical trial reporting in immuno-oncology.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs